
This post hoc analysis examined efficacy and zzso of zzso zzso in patients with major depressive disorder switched from blinded zzso zzso extended release zzso or zzso 

Patients who completed 8 weeks of zzso therapy with zzso zzso zzso zzso zzso zzso zzso zzso zzso or zzso zzso zzso zzso enrolled in a zzso zzso extension study and received zzso 200 to 400 zzso zzso zzso Hamilton Depression zzso zzso zzso was assessed separately for zzso and zzso to zzso zzso zzso during the first month of zzso zzso was zzso 

Among zzso zzso zzso zzso to zzso zzso zzso zzso and zzso mean decreases in zzso scores were zzso zzso and zzso zzso zzso response rates were zzso zzso and zzso zzso Although zzso zzso zzso zzso to zzso zzso zzso zzso and zzso had more modest decreases on the zzso response rates were higher zzso zzso and zzso zzso Rates of adverse events were highest during week 1, and decreased afterward for the remainder of the first month of zzso 

Among zzso to 8 weeks of zzso zzso zzso zzso or zzso zzso to zzso subsequently responded to zzso zzso Over zzso of zzso to zzso therapy maintained response on zzso zzso The switch from zzso zzso to zzso was well zzso 

